Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative
Abstract The increased incidence of antibiotic resistant ‘superbugs’ has amplified the use of broad spectrum antibiotics worldwide. An unintended consequence of antimicrobial treatment is disruption of the gastrointestinal microbiota, resulting in susceptibility to opportunistic pathogens, such as C...
Guardado en:
Autores principales: | Melanie L. Hutton, Bliss A. Cunningham, Kate E. Mackin, Shelley A. Lyon, Meagan L. James, Julian I. Rood, Dena Lyras |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/287f80b5616c443694627a600e1f3867 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile.
por: Kate E Mackin, et al.
Publicado: (2013) -
Programmed cellular necrosis mediated by the pore-forming alpha-toxin from Clostridium septicum.
por: Catherine L Kennedy, et al.
Publicado: (2009) -
Structural Characterization of <named-content content-type="genus-species">Clostridium sordellii</named-content> Spores of Diverse Human, Animal, and Environmental Origin and Comparison to <named-content content-type="genus-species">Clostridium difficile</named-content> Spores
por: Rebecca Rabi, et al.
Publicado: (2017) -
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
por: Navalkele BD, et al.
Publicado: (2018) -
Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
por: Yang Song, et al.
Publicado: (2013)